Celeris Therapeutics GmbH

With its innovative closed-loop platform, Celeris Therapeutics pioneers the AI-driven development of small molecule degraders. CelerisTx’s drug pipeline focuses on oncology and collaborates therapeutics with pharmaceutical and biotech companies for multiple indications.